Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. RESEARCH COLLABORATION AND...Collaboration and License Agreement • November 22nd, 2021 • Bionomics Limited/Fi • Pharmaceutical preparations • New York
This Research Collaboration and License Agreement (this “Agreement”) is effective as of June , 2014 (the “Effective Date”), and is entered into by and between MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey, United States (“Merck”), and BIONOMICS LIMITED, a corporation organized and existing under the laws of Australia (“Bionomics”).
FIRST AMENDMENT - RESEARCH COLLABORATION AND LICENSE AGREEMENT BIONOMICS LIMITED MERCK SHARP & DOHME CORP. Johnson Winter & Slattery LAWYERS Level 9, 211 Victoria Square ADELAIDE SA 5000 T +61 8 8239 7111 | F +61 8 8239 7100 SYDNEY | PERTH | MELBOURNE...Collaboration and License Agreement • November 22nd, 2021 • Bionomics Limited/Fi • Pharmaceutical preparations
B The Parties have agreed to vary the terms of the Research Collaboration and License Agreement as set out in this First Amendment.
IP LICENCE AGREEMENT BIONOMICS LIMITED CARINA BIOTECH PTY LTDLicence Agreement • November 22nd, 2021 • Bionomics Limited/Fi • Pharmaceutical preparations
Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. FOURTH AMENDMENT TO RESEARCH...Research Collaboration and License Agreement • November 22nd, 2021 • Bionomics Limited/Fi • Pharmaceutical preparations
This Fourth Amendment To Research Collaboration And License Agreement (“Fourth Amendment”), effective as of the date of last signature below (the “Fourth Amendment Effective Date”), confirms the mutual understanding between Merck Sharp & Dohme Corp. (“Merck”) and Bionomics Limited (“Bionomics”).
BIONOMICS LIMITED MR ADRIAN HINTON CONSULTANCY AGREEMENTConsultancy Agreement • November 22nd, 2021 • Bionomics Limited/Fi • Pharmaceutical preparations • South Australia
A Bionomics requires the Consultant to provide professional consultancy services (“the Services”) to Bionomics during the term of this Agreement, as required from time to time.
Subscription AgreementSubscription Agreement • November 22nd, 2021 • Bionomics Limited/Fi • Pharmaceutical preparations
Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. SECOND AMENDMENT TO RESEARCH...Collaboration and License Agreement • November 22nd, 2021 • Bionomics Limited/Fi • Pharmaceutical preparations
This Second Amendment To Research Collaboration And License Agreement (“Second Amendment”), effective as of the date of last signature below (the “Second Amendment Effective Date”), confirms the mutual understanding between Merck Sharp & Dohme Corp. (“Merck”) and Bionomics Limited (“Bionomics”).
Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. THIRD AMENDMENT TO RESEARCH...Collaboration and License Agreement • November 22nd, 2021 • Bionomics Limited/Fi • Pharmaceutical preparations
This Third Amendment to Research Collaboration And License Agreement (“Third Amendment”), effective as of the date of last signature below (the “Third Amendment Effective Date”), confirms the mutual understanding between Merck Sharp & Dohme Corp. (“Merck”) and Bionomics Limited (“Bionomics”).
BIONOMICS LIMITED EXECUTIVE EMPLOYMENT AGREEMENTBionomics Limited • November 22nd, 2021 • Bionomics Limited/Fi • Pharmaceutical preparations
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made as of June 2021 by and between Bionomics Limited (ABN 53 075 582 740) (the “Company”), and Errol B. De Souza, an individual (“you”) (and, together, “Parties”).
Placement AgreementBionomics Limited/Fi • November 22nd, 2021 • Pharmaceutical preparations
B The Company has agreed to issue, and BVF has agreed to subscribe for or procure subscriptions for, the Placement Shares on and subject to the terms in this document.
